December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mahipal Singh Bhanot: From Fear to Faith – Fortis Gurugram’s Legacy in Hematology
Dec 24, 2024, 17:41

Mahipal Singh Bhanot: From Fear to Faith – Fortis Gurugram’s Legacy in Hematology

Mahipal Singh Bhanot, Senior Vice President and Business Head shared on LinkedIn:

“From Fear to Faith: Fortis Gurugram’s Legacy in Hematology

Hematology has come a long way from its underrecognized beginnings to becoming a cornerstone of specialized care. At Fortis Hospital Gurugram, under the visionary leadership of Dr. Rahul Bhargava and Dr Vikas Dua the Hematology and Bone Marrow Transplant (BMT) team has revolutionized care for complex blood disorders. With 1,200+ bone marrow transplants and a 22-bedded transplant unit, Fortis Gurugram has emerged as India’s leading treatment center for thalassemia, sickle cell anemia, leukemia and BMT.

Fortis Gurugram has redefined blood disorder treatments through its comprehensive team of 15 specialists, bringing together experts from critical care, infectious diseases, geneticists, geriatric specialists, nurse practitioners and paramedical staff all under one roof. This formidable, multidisciplinary team ensures holistic care at every stage of treatment, addressing even the most complex patient needs.

Breakthroughs like NexCAR19, India’s first commercially approved CAR-T cell therapy launched in January 2024, have set new standards for treating resistant B-cell lymphoma and leukemia. Looking ahead, Fortis is innovating solutions to challenges like Graft-versus-Host Disease (GVHD) in BMTs, particularly for haploidentical and unrelated donor transplants. By adopting cutting-edge technologies and practices, Fortis is overcoming past limitations to deliver safer, more effective therapies for global patients.

At Fortis Institute of Blood Disorders, innovation goes hand-in-hand with ongoing and future-focused research. From drug-related studies to exploring next-generation therapies, we encourage collaboration with researchers and innovators to join hands with us so that we can collectively advance the fight against blood cancers.

For us, the mission is not competition it’s about raising the bar to deliver world-class outcomes. With a vision for 2025 and beyond, we will continue to innovate, improve, and expand our expertise to transform lives. By integrating accurate diagnoses, advanced therapies, and multidisciplinary care, Fortis Gurugram stands as a global hub of hope, healing, and cutting-edge treatment.”